Michael P. Johnson - 12 Feb 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Feb 2026, 19:30:42 UTC
Prior SEC filing
03 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson

Key filing fact

Michael P. Johnson filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 17 Feb 2026.

Key facts

  • This page summarizes Michael P. Johnson's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
  • 10 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 17 Feb 2026, 19:30.

Change

  • Previous filing in this sequence was filed on 03 Jun 2025.
  • Current net transaction value: -$112,024.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001917747 Primary reporting owner

Johnson Michael Perkins

Relationship
Executive Vice President
Address
ONE IDEXX DRIVE, WESTBROOK
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson
Signature date
17 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+176
Change %
+7.3%
Price
$0.000000
Shares after
2,576
Date
14 Feb 2026
Ownership
Direct
Footnotes
F1
IDXX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+179
Change %
+6.9%
Price
$0.000000
Shares after
2,755
Date
14 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+218
Change %
+7.9%
Price
$0.000000
Shares after
2,973
Date
14 Feb 2026
Ownership
Direct
IDXX transaction

Common Stock

Tax liability

Transaction value
$112,024
Shares
-178
Change %
-6%
Price
$629.35
Shares after
2,795
Date
14 Feb 2026
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Award

Transaction value
$0
Shares
+3,207
Change %
Price
$0.000000
Shares after
3,207
Date
12 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,207
Exercise price
$617.20
Footnotes
F3
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Award

Transaction value
$0
Shares
+162
Change %
Price
$0.000000
Shares after
162
Date
12 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
162
Exercise price
$617.20
Footnotes
F4
IDXX transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+770
Change %
Price
$0.000000
Shares after
770
Date
12 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
770
Exercise price
Footnotes
F5
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-176
Change %
-50%
Price
$0.000000
Shares after
176
Date
14 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
176
Exercise price
Footnotes
F6
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-179
Change %
-33%
Price
$0.000000
Shares after
356
Date
14 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
179
Exercise price
Footnotes
F7
IDXX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-218
Change %
-25%
Price
$0.000000
Shares after
652
Date
14 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
218
Exercise price
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Includes a total of 34.345 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on June 30, 2025, September 30, 2025 and December 31, 2025. There are a total of 163.687 shares held in the ESPP which has been increased by 0.001 shares due to a rounding calculation of previously issued fractional shares.

Footnote F2

Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.

Footnote F3

Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.

Footnote F4

Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.

Footnote F5

Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027.

Footnote F6

Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.

Footnote F7

Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.

Footnote F8

Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .